Sales of Dentons bio-amino acids fell 4.8% in the first half of 2017

on August 28, 2017 Dentons Biochemical Technology Group Co., Ltd(the "Group") Board of Directors announced a summary of its company and its subsidiaries' consolidated results for the six months ended June 30, 2017:d4GGroup reported a net loss of HK$333,000,000 for the six months ended June 30, 2017 (the "Review") HK$000), net current liabilities of the Group as at the end of the year was approximately HK$4,839,500,000 (approximately HK$3,597,400,000 as at 31 December 2016) and net liabilities of approximately HK$2,178,800,000 (approximately HK$1,804,1000 000 as at 31 December 2016)d4G
The Group's consolidated earnings decreased slightly by about 2.2% during the review period to HK$2,017,100,000 (HK$2,062,300,000 in 2016), mainly due to an 8.0% decrease in the average selling price of the upstream division to HK$2,048/tonne (HK$2,226/tonne in 2016)However, lower raw material costs, the recovery of the lysine market and operational optimization have improved the Group's performance during the review periodAs a result, gross profit and EBITDA (i.e., earnings before interest, tax, depreciation and amortisation) were HK$356,800,000 and HK$85,000,000 respectively during the review period, compared with gross profit and LBITDA (i.e., loss before interest, tax, depreciation and amortisation) of HK$83,900,000 and HK$24,900,000, respectively, in the same period a year earlierThe Company's net loss during the review period was HK$333,000,000 (HK$599,500,000 in 2016) due to the low utilization of the Xinglongshan site and the Group's high level of debtThe amino acid division, which includes lysine, methionine and sucone products, earned approximately HK$1,006,000,000 (HK$1,033,600,000 in 2016), accounting for 49.9% of Group revenue (50.1% in 2016)Sales of the amino acid segment decreased slightly by 4.8% to 179,000 metric tons (188,000 metric tons in 2016)However, margin of gross margin of 20.7% (11.2% in 2016) rose to approximately HK$208,500,000 (HK$115,400,000 in 2016) as a result of facility upgrades and realignment of the product portfolio to meet market needsExport sales of approximately 121,000 tonnes of amino acids (58,000 tonnes in 2016) increased to HK$460,000,000 (HK$381,600,000 in 2016) during the review periodd4GOn August 28, 2017, the Board of Directors of Dentons Biochemical Technology Group Co., Ltd(the "Group") announced a summary of its company and its subsidiaries' consolidated results for the six months ended June 30, 2017: d4G The Group reported a net loss of HK$333,000,000 for the six months ended June 30, 2017 (the "Review") HK$00,000), net current liabilities of the Group as at the end of the year was approximately HK$4,839,500,000 (approximately HK$3,597,400,000 as at 31 December 2016) and hk$2,178,800,000 (approximately HK$1,804,1000 as at 31 December 2016) d4G
　　The Group's consolidated earnings decreased slightly by about 2.2% during the review period to HK$2,017,100,000 (HK$2,062,300,000 in 2016), mainly due to an 8.0% decrease in the average selling price of the upstream division to HK$2,048/tonne (HK$2,226/tonne in 2016) However, lower raw material costs, the recovery of the lysine market and operational optimization have improved the Group's performance during the review period As a result, gross profit and EBITDA (i.e., earnings before interest, tax, depreciation and amortisation) were HK$356,800,000 and HK$85,000,000 respectively during the review period, compared with gross profit and LBITDA (i.e., loss before interest, tax, depreciation and amortisation) of HK$83,900,000 and HK$24,900,000, respectively, in the same period a year earlier The Company's net loss during the review period was HK$333,000,000 (HK$599,500,000 in 2016) due to the low utilization of the Xinglongshan site and the Group's high level of debt The amino acid division, which includes lysine, methionine and sucone products, earned approximately HK$1,006,000,000 (HK$1,033,600,000 in 2016), accounting for 49.9% of Group revenue (50.1% in 2016) Sales of the amino acid segment decreased slightly by 4.8% to 179,000 metric tons (188,000 metric tons in 2016) However, margin of gross margin of 20.7% (11.2% in 2016) rose to approximately HK$208,500,000 (HK$115,400,000 in 2016) as a result of facility upgrades and realignment of the product portfolio to meet market needs Export sales of approximately 121,000 tonnes of amino acids (58,000 tonnes in 2016) increased to HK$460,000,000 (HK$381,600,000 in 2016) during the review period d4G